Study Supplies Sample Clauses

Study Supplies. Předpokládá se, že Hlavní zkoušející do Studie zařadí všechny subjekty, které se účastnily Hlavní studie (PRV-031-001, PROTECT). Podrobná kritéria pro zařazování subjektů do Studie jsou uvedena v Protokolu.
Study Supplies. ABBOTT shall provide INSTITUTION with sufficient quantity of Study Product and CRFs to conduct each Study, as well as any other compounds, materials and information which the Protocol specifies or other materials as ABBOTT deems necessary to conduct the Study at no cost solely for use by INSTITUTION and Principal Investigator in the conduct of the applicable Study. Neither INSTITUTION nor Principal Investigator will use any of the Study Product, CRFs or any other compounds, materials and information provided by ABBOTT for any purpose other than to conduct the applicable Study pursuant to the Protocol under the applicable Statement of Work. All such Study Product, CRFs and other information provided by ABBOTT in connection with this Master Agreement are and will remain the sole property of ABBOTT. INSTITUTION represents and certifies that for each Study during the Study Term, it will and will require each Principal Investigator to ensure that: (a) the supply of Study Product is adequate and that the Study Product will be stored and handled in accordance with ▇▇▇▇▇▇’▇ written instructions and as set forth in the labeling of the applicable Study Product and in accordance with applicable regulatory requirement(s); (b) the Study Product will not be used past the labeled expiration date; and (c) upon conclusion of a Study or termination of a Statement of Work or at ▇▇▇▇▇▇’▇ request, any remaining or expired Study Product, CRFs, as well as any other Study compounds, Study materials and Study information provided by ABBOTT under the applicable Statement of Work will be returned to ABBOTT, at ▇▇▇▇▇▇’▇ expense, in accordance with the Protocol and in compliance with applicable requirements governing the shipment of such Study Product or will be disposed of pursuant to the Protocol, and any local, state and federal laws and regulations governing the disposal of such Study Product, CRFs or any other Study compounds, Study materials and Study information. For Study Product, CRFs or other Study compounds, Study materials and Study information disposed by or on behalf of INSTITUTION, INSTITUTION represents and certifies that it has the necessary facilities, expertise and regulatory approvals required to dispose such Study Product, CRFs and other Study compounds, Study materials and Study information and that such disposal will be at INSTITUTION’s expense. INSTITUTION will document such return or disposal of such Study Product, CRFs, any other Study compounds, Study materi...
Study Supplies. (a) SPONSOR shall provide PAREXEL with a sufficient quantity of the Study Drug to conduct the Study, as well as any other compounds, materials and information which the Protocol specifies SPONSOR shall deliver or which SPONSOR deems necessary to conduct the Study in accordance with the Protocol (all such items, “Study Materials”). (b) All Study Drug, and Study Materials are and shall remain the sole property of SPONSOR. PAREXEL, the Principal Investigator and each Subinvestigator shall take all reasonable steps to handle, store, use and dispose of the Study Drug and any Study Materials in accordance with the Protocol. PAREXEL, the Principal Investigator and each Subinvestigator shall not release any Study Drug to any third party, with the exception of Study subjects, (including without limitation any governmental agency, any other investigator or any other third party) without the prior written express approval from SPONSOR, except in cases where they are required by law to release the Study Drug to a regulatory agency acting within the scope of its regulatory authority, in which case, PAREXEL, and the Principal Investigator/Subinvestigator will promptly notify SPONSOR of such action.

Related to Study Supplies

  • Supplies 1. Supplies are defined as consumable items necessary to carry out the services under this Contract including medical supplies, drugs, janitorial supplies, office supplies, patient educational supplies, software, and any items of tangible personal property other than those defined as equipment above. 2. Tangible personal property includes controlled assets, including firearms, regardless of the acquisition cost, and the following assets with an acquisition cost of $500 or more, but less than $5,000, which includes desktop and laptop computers (including notebooks, tablets and similar devices), non-portable printers and copiers, emergency management equipment, communication devices and systems, medical and laboratory equipment, and media equipment are also considered Supplies. 3. Prior approval by the System Agency of the purchase of Controlled Assets is not required, but such purchases must be reported on the Grantees Property Inventory Form.

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Durable Medical Equipment (DME), Medical Supplies, Prosthetic Devices, Enteral Formula or Food, and Hair Prosthesis (Wigs) This plan covers durable medical equipment and supplies, prosthetic devices and enteral formula or food as described in this section. DME is equipment which: • can withstand repeated use; • is primarily and customarily used to serve a medical purpose; • is not useful to a person in the absence of an illness or injury; and • is for use in the home. DME includes supplies necessary for the effective use of the equipment. This plan covers the following DME: • wheelchairs, hospital beds, and other DME items used only for medical treatment; and • replacement of purchased equipment which is needed due to a change in your medical condition or if the device is not functional, no longer under warranty, or cannot be repaired. DME may be classified as a rental item or a purchased item. In most cases, this plan only pays for a rental DME up to our allowance for a purchased DME. Repairs and supplies for rental DME are included in the rental allowance. Medical supplies are consumable supplies that are disposable and not intended for re- use. Medical supplies require an order by a physician and must be essential for the care or treatment of an illness, injury, or congenital defect. Covered medical supplies include: • essential accessories such as hoses, tubes and mouthpieces for use with medically necessary DME (these accessories are included as part of the rental allowance for rented DME); • catheters, colostomy and ileostomy supplies, irrigation trays and surgical dressings; and • respiratory therapy equipment. This plan covers diabetic equipment and supplies for the treatment of diabetes in accordance with R.I. General Law §27-20-30. Covered diabetic equipment and supplies include: • therapeutic or molded shoes and inserts for custom-molded shoes for the prevention of amputation; • blood glucose monitors including those with special features for the legally blind, external insulin infusion pumps and accessories, insulin infusion devices and injection aids; and • lancets and test strips for glucose monitors including those with special features for the legally blind, and infusion sets for external insulin pumps. The amount you pay differs based on whether the equipment and supplies are bought from a durable medical equipment provider or from a pharmacy. See the Summary of Pharmacy Benefits and the Summary of Medical Benefits for details. Coverage for some diabetic equipment and supplies may only be available from either a DME provider or from a pharmacy. Visit our website to determine if this is applicable or call our Customer Service Department. Prosthetic devices replace or substitute all or part of an internal body part, including contiguous tissue, or replace all or part of the function of a permanently inoperative or malfunctioning body part and alleviate functional loss or impairment due to an illness, injury or congenital defect. Prosthetic devices do not include dental prosthetics. This plan covers the following prosthetic devices as required under R.I. General Law § 27-20-52: • prosthetic appliances such as artificial limbs, breasts, larynxes and eyes; • replacement or adjustment of prosthetic appliances if there is a change in your medical condition or if the device is not functional, no longer under warranty and cannot be repaired; • devices, accessories, batteries and supplies necessary for prosthetic devices; • orthopedic braces except corrective shoes and orthotic devices used in connection with footwear; and • breast prosthesis following a mastectomy, in accordance with the Women’s Health and Cancer Rights Act of 1998 and R.I. General Law 27-20-29. The prosthetic device must be ordered or provided by a physician, or by a provider under the direction of a physician. When you are prescribed a prosthetic device as an inpatient and it is billed by a provider other than the hospital where you are an inpatient, the outpatient benefit limit will apply. Enteral formula or food is nutrition that is absorbed through the intestinal tract, whether delivered through a feeding tube or taken orally. Enteral nutrition is covered when it is the sole source of nutrition and prescribed by the physician for home use. In accordance with R.I. General Law §27-20-56, this plan covers enteral formula taken orally for the treatment of: • malabsorption caused by Crohn’s Disease; • ulcerative colitis; • gastroesophageal reflux; • chronic intestinal pseudo obstruction; and • inherited diseases of amino acids and organic acids. Food products modified to be low protein are covered for the treatment of inherited diseases of amino acids and organic acids. Preauthorization may be required. The amount that you pay may differ depending on whether the nutrition is delivered through a feeding tube or taken orally. When enteral formula is delivered through a feeding tube, associated supplies are also covered. This plan covers hair prosthetics (wigs) worn for hair loss suffered as a result of cancer treatment in accordance with R.I. General Law § 27-20-54 and subject to the benefit limit and copayment listed in the Summary of Medical Benefits. This plan will reimburse the lesser of the provider’s charge or the benefit limit shown in the Summary of Medical Benefits. If the provider’s charge is more than the benefit limit, you are responsible for paying any difference. This plan covers Early Intervention Services in accordance with R.I. General Law §27- 20-50. Early Intervention Services are educational, developmental, health, and social services provided to children from birth to thirty-six (36) months. The child must be certified by the Rhode Island Department of Human Services (DHS) to enroll in an approved Early Intervention Services program. Services must be provided by a licensed Early Intervention provider and rendered to a Rhode Island resident. Members not living in Rhode Island may seek services from the state in which they reside; however, those services are not covered under this plan. Early Intervention Services as defined by DHS include but are not limited to the following: • speech and language therapy; • physical and occupational therapy; • evaluation; • case management; • nutrition; • service plan development and review; • nursing services; and • assistive technology services and devices.

  • Laboratory a. Drug tests shall be conducted by laboratories licensed and approved by SAMSHA which comply with the American Occupational Medical Association (AOMA) ethical standards. Upon advance notice, the parties retain the right to inspect the laboratory to determine conformity with the standards described in this policy. The laboratory will only test for drugs identified in this policy. The City shall bear the cost of all required testing unless otherwise specified herein. b. Tests for all controlled substances, except alcohol, shall be by oral fluid testing and shall consist of two procedures, a screen test and, if that is positive, a confirmation test. c. To be considered positive for reporting by the laboratory to the City, both samples must be tested separately in separate batches and must also show positive results on the confirmatory test. d. In the event of a positive test, the testing laboratory will perform an automatic confirmation test on the original specimen at no cost to the Covered Employee. In addition, the testing laboratory shall preserve a sufficient specimen to permit an independent re-testing at the Covered Employee’s request and expense. The same, or any other, approved laboratory may conduct re-tests. The laboratory shall endeavor to notify the designated MRO of positive drug, alcohol, or adulterant tests results within five (5) working days after receipt of the specimen.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.